PMID: 26351528Sep 10, 2015Paper

Quantification of liver fibrosis in chronic hepatitis B virus infection

Journal of Medicine and Life
C F JieanuV L Purcărea

Abstract

Chronic hepatitis B virus infection (HBV) is considered a global public issue with more than 78.000 people per year dying of its evolution. With liver transplantation as the only viable therapeutic option but only in end-stage disease, hepatitis B progression may generally be influenced by various factors. Assessing fibrosis stage plays an important part in future decisions on the patients' wealth with available antiviral agents capable of preventing fibrosis passing to an end-stage liver disease. Several methods have been taken into consideration as an alternative for HBV quantification status, such as imaging techniques and serum based biomarkers. Magnetic resonance imaging, ultrasound, and elastography are considered non-invasive imaging techniques frequently used to quantify disease progression as well as patients future prognostic. Consequently, both direct and indirect biomarkers have been studied for differentiating between fibrosis stages. This paper reviews the current standings in HBV non-invasive liver fibrosis quantification, presenting the prognostic factors and available assessment procedures that might eventually replace liver biopsy.

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Korean Journal of Radiology : Official Journal of the Korean Radiological Society
Jeong Eun LeeByung Ihn Choi
JPMA. the Journal of the Pakistan Medical Association
Sobia HassanShahnaz Imdad Kehar
Liver International : Official Journal of the International Association for the Study of the Liver
Samer S El-KamaryGamal Esmat
© 2021 Meta ULC. All rights reserved